B
Bluesight (Formerly Kit Check)
Leader in automated hospital pharmacy kit tracking
About Bluesight (Formerly Kit Check)
Bluesight addresses supply chain inefficiencies and mitigates risks by leveraging AI and machine learning to provide actionable analytics throughout the medication lifecycle. Its suite of Medication Intelligence™ solutions simplifies, enhances visibility, and brings predictability to medication management. Serving over 1,600 hospitals in the U.S. and Canada, Bluesight helps optimize pharmacy practices by improving operational efficiency, reducing medication costs, and increasing compliance and safety. The company operates in the healthcare sector, primarily targeting hospital pharmacies. Bluesight's business model revolves around offering software solutions that generate revenue through subscriptions and service fees.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Alexandria, United States
- Employees
- 214
- Open positions
- None listed
- Dealroom signal
- 76.9/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
- Investment activity
- 1 company, latest Jul 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jul 2023 | $0 | — | Thoma Bravo | ↗ |
| DEBTDebt | Jan 2017 | $7M | — | Armentum Partners | — |
Growth signals
Latest recorded traffic for Bluesight (Formerly Kit Check) is 1.2K monthly website visits, up 300% over the last three months. Bluesight (Formerly Kit Check)'s team grew 2.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
- AVAberdare Ventures
Kleiner Perkins
Rock Health
Mayo Clinic
Mohr Davidow Ventures
Series A4 investors entered at this stage
New Leaf Venture Partners
LionBird
Kaiser Permanente Ventures
Rex Health Ventures
Series B and later5 investors entered at this stage
Baxter Ventures- CHCircuit Health
Black Granite Capital
Armentum Partners
Thoma Bravo
Other known investors3 additional known investors
Easton Capital Investment Group
Rock Health Capital
Sands Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bluesight (Formerly Kit Check) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bluesight (Formerly Kit Check)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.